When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Focal seizures

Evidencia revisada por última vez: 14 Apr 2026
Tema actualizado por última vez: 28 Jan 2026

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • movement of one side of the body or one specific body part
  • premonitory sensation or experience (fear, epigastric sensation, déjà vu, jamais vu)
  • automatisms (picking at clothes, smacking of the lips)
  • temporary aphasia
  • staring and being unaware of surroundings
Todos los datos

Otros factores de diagnóstico

  • postictal focal neurological deficit (Todd paralysis, aphasia)
  • persistent focal neurological deficit
  • poor memory
  • stigmata of neurocutaneous syndromes
Todos los datos

Factores de riesgo

  • febrile seizure
  • traumatic brain injury
  • central nervous system (CNS) infection
  • stroke
  • brain tumor
  • intellectual disability and/or cerebral palsy
  • dementia
  • family history of seizures
  • intracranial vascular malformations
  • malformations of cortical development (MCDs)
  • male sex
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • blood glucose
  • CBC
  • electrolyte panel
  • toxicology screen
  • lumbar puncture and cerebrospinal fluid analysis
  • CT head
  • MRI brain
  • electroencephalogram (EEG)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • video/electroencephalogram (EEG) long-term monitoring (LTM)
  • PET scan
  • single photon emission computed tomography (SPECT) scan
  • functional MRI scan
  • magnetoencephalography (MEG) scan
  • neuropsychological testing
  • Wada test
Todos los datos

Pruebas emergentes

  • 7T MRI scan

Algoritmo de tratamiento

Agudo

acute repetitive seizures: in the community

acute repetitive seizures: in the hospital

En curso

adults <60 years old: nonpregnant or no risk of pregnancy

adults ≥60 years old

women of childbearing potential

pregnant

children

Colaboradores

Autores

Ramses Ribot, MD

Assistant Professor of Clinical Neurology

Department of Neurology, Epilepsy Division

University of Miami, Miller School of Medicine

Miami

FL

Declarações

RR declares that he has no competing interests.

Andres M. Kanner, MD, FANA, FAES, FAAN

Professor of Clinical Neurology

Director, Comprehensive Epilepsy Center and Head, Section of Epilepsy

Department of Neurology

University of Miami, Miller School of Medicine

Miami

FL

Declarações

AMK has received honoraria from Eisai Laboratories for lectures given at international scientific meetings, and from the Epilepsy Foundation of America for being Co-Editor in Chief of Epilepsy.com. AMK is an author of a number of references cited in this topic.

Agradecimentos

Dr Ramses Ribot and Dr Andres M. Kanner would like to gratefully acknowledge Dr Vikram R. Rao, Dr John D. Hixson, and Dr Jeffrey Cohen, previous contributors to this topic.

Declarações

VRR served as a paid consultant for Neuropace, Inc., manufacturer of the Responsive Neurostimulation (RNS) System. JDH has received research funding and consultancy funds from UCB, Inc. JC declares that he has no competing interests.

Revisores

Edward Bromfield, MD

Chief

Epilepsy Division

Brigham and Women's Hospital

Associate Professor of Neurology

Harvard Medical School

Boston

MA

Declarações

At the time of review, EB declared that between 2004 and 2009, he received speaking honoraria from UCB Pharma, Novartis, Abbott Laboratories, GlaxoSmithKline, and Pfizer. He received consulting fees from UCB Pharma, Genzyme, and Spherics, and research funding from UCB Pharma. Unfortunately, we have since been made aware that EB is deceased.

Angus A. Wilfong, MD

Associate Professor

Pediatrics and Neurology

Baylor College of Medicine

Medical Director

Comprehensive Epilepsy Program

Texas Children's Hospital

Houston

TX

Declarações

AAW declares that he has no competing interests.

Cigdem I. Akman, MD

Assistant Professor

Division of Pediatric Neurology

Columbia University College of Physicians and Surgeons

New York

NY

Declarações

Not disclosed.

Pasquale Striano, MD, PhD

Consultant Neurologist

Muscular and Neurodegenerative Diseases Unit

"G Gaslini" Institute

Genova

Epilepsy Centre

Federico II University

Napoli

Italy

Disclosures

PS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.Full text  Abstract

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21.Full text  Abstract

Leone MA, Giussani G, Nevitt SJ, et al. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2021 May 4;(5):CD007144.Full text  Abstract

American Academy of Neurology. Update: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy. Jun 2018 [internet publication].Full text  Abstract

American Academy of Neurology. Update: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy. Jun 2018 [internet publication].Full text

Nevitt SJ, Sudell M, Cividini S, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Syncope
    • Transient ischemic attack (TIA)
    • Sleep disorders
    More Differentials
  • Guidelines

    • Epilepsies in children, young people and adults
    • Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary
    More Guidelines
  • Patient information

    Epilepsy: what is it?

    Epilepsy: what are the treatment options?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer